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With-no-lysine (WNK) kinases control blood pressure and potassium homeostasis, predominantly by 65 regulating membrane expression and activity of the thiazide-sensitive Na-Cl cotransporter (NCC) in the distal 66 convoluted tubule (DCT). These kinases signal via serine/threonine protein kinase 39 (SPAK; STK39) and 67 oxidative stress-response 1 (OxSR1 or OSR1; OXSR1), which directly phosphorylate and activate the transport 68 protein (19, 30) . The human Mendelian disease Familial Hyperkalemic Hypertension (FHHt, also called 69 pseudohypoaldosteronism type 2 or Gordon syndrome) results from activation of this signaling pathway in the 70 distal nephron (21) . FHHt patients exhibit hyperkalemia, metabolic acidosis, and hypertension, symptoms that 71 largely disappear during treatment with thiazide diuretics (13) . FHHt can be caused by mutations in WNK1 or 72 WNK4 (32), or in the cullin-RING ligase (CRL) proteins cullin 3 (Cul3) (4) and kelch-like 3 (KLHL3) (28) . 73
Cul3 is part of an E3 ubiquitin ligase complex that regulates protein degradation. CRLs do not degrade proteins 74 directly, but instead attach strings of ubiquitin moieties to a protein, thereby targeting it for degradation, 75 typically within the proteasome. Cullin acts as a scaffold protein for the other CRL subunits. It is now clear that 76 WNK kinases are targets for CRLs. The substrate adaptor KLHL3, binds both WNK kinases and Cul3, bringing 77 the WNK into proximity to the catalytic region of the CRL, thereby permitting ubiquitylation (18, 25) . The 78 WNK4 or KLHL3 mutations that cause disease, do so by disrupting these binding reactions, permitting WNKs 79 to accumulate (31). The Cul3 mutations that cause FHHt, however, do not decrease substrate adaptor binding 80 (27, 31) ; although mouse models indicate that WNKs are not degraded normally (24), the precise mechanisms 81 involved remain controversial. 82
An important feature of CRL activity is the attachment of NEDD8 (neuronal precursor cell expressed 83 developmentally down-regulated protein 8) through a process called neddylation. NEDD8 attachment is 84 required to activate CRLs by increasing the flexibility of the cullin-ring structure, allowing the transfer of 85 ubiquitin from the RING protein to the target substrate (3, 20, 23) . The reverse process, deneddylation, is 86 facilitated by the multi-subunit COP9 signalosome (CSN) complex. The CSN interacts with CRLs and removes 87 NEDD8 through its catalytically-active CSN5 subunit, also known as JAB1 (jun activation domain-binding 88 protein-1) (6) . Although a simple model originally suggested that neddylated Cul3 is active, whereas 89 unneddylated Cul3 is inactive, inhibition of CSN paradoxically increases, rather than decreases, the abundance 90 of substrate proteins in vivo (22) . It appears instead that, while neddylation of cullins is indeed essential to 91 activate them, it also makes them unstable and prone to degradation (35) . Thus, the effects of neddylation on 92 cullin activity and abundance are complex. 93
All known FHHt-causing Cul3 mutations cause deletion of exon 9, resulting in a mutant protein that 94 lacks 57 amino acid residues (Cul3Δ403-459) (4). Previous work by our group (14) , and confirmed by others 95 (24), showed that Cul3Δ403-459, expressed in cells, is hyperneddylated, compared with wild type (WT), 96 suggesting either that it is more susceptible to neddylation or that it is resistant to deneddylation. Schumacher et that the deleted segment was responsible. Exon 9 of Cul3 encodes the 4-helix bundle (4HB) domain. Min et al. 99 (15) demonstrated that the CSN binding site for the closely related cullin 1 protein was located within the 4HB 00 and α/β 1 domains. However, the CSN binding site for Cul3 has yet to be determined. 01
Cul3Δ403-459 has an increased association with bric-a-brac, tramtrack, broad-complex (BTB)-Kelch 02 substrate adaptor proteins, including KLHL3 (10, 14, 24) . The FHHt Cul3 mutant strongly ubiquitylated 03 KLHL3 (14, 24) leading to decreased abundance, in vitro (14) . However, administration of the non-specific 04 neddylation inhibitor, MLN4924, which prevents NEDD8 conjugation and presumably inactivates CRLs, only 05 partially normalized KLHL3 abundance. Additionally, the enhanced interaction of KLHL3 with Cul3Δ403-459 06 remained in the absence of neddylation. The results indicate that Cul3Δ403-459 may have neddylation-07 dependent and neddylation-independent effects. Here, we examined the mechanisms and consequences of 08
Cul3Δ403-459 hyperneddylation, and identified novel ligase dependent, and ligase independent mechanisms for 09 the human disease. 10 11
Materials and Methods 12
Antibodies 13
Antibodies used are described in Table 1.  14   15 Cell culture, plasmids, and transfections 16
For cell culture experiments HEK293 cells were used unless otherwise stated. CRISPR-Cas9-edited 17 Cul3 knockdown HEK293T cells (HEK293T Cul3-KO ) were previously reported (10). Cells were maintained in 18 DMEM supplemented with 10% FBS, 25 mM HEPES, 100 units/ml penicillin, 100 µg/ml streptomycin. Cells 19 were transiently transfected using Lipofectamine 2000 (Ambion, Foster City, CA, USA; Invitrogen). Cul3 20 constructs were made by amplifying FLAG-Cul3 WT DNA using Phusion Hot Start II DNA Polymerase 21 (Thermo Fisher Scientific, Boston, MA, USA) with the appropriate primers, purified with the PureLink PCR 22
Purification Kit (Invitrogen) and properly digested. The products were then extracted using the UltraClean 23
GelSpin DNA Extraction Kit (MoBio Laboratories, Inc., Carlsbad, CA, USA) and ligated into N-terminal GST 24 tag mammalian plasmid, pSF-CMV-Puro-NH2-GST (Oxford Genetics, Oxford, UK), with T4 DNA Ligase 25 (New England BioLabs, Ipswich, MA, USA). Ligated constructs were transformed using DH5α competent cells 26 (Thermo Fisher Scientific) and plasmid DNA was purified with either the QIAprep Spin Miniprep Kit or 27
HiSpeed Plasmid Midi Kit (Qiagen, Hilden, Germany). Sanger sequencing was performed for all constructs. 28
For siRNA experiments, either 40 nM of COPS5 siRNA (Ambion) or control siRNA was transfected 29 along with DNA plasmids. Cells were harvested at 36 h post-transfection. 30
For cycloheximide chase experiments, cycloheximide was added 36 h after transfection at a 31 concentration of 100 µg/ml and the cells were lysed at the time points indicated. 32
For MG132, chloroquine, 3-methyadenine, MLN4924, and tBHQ experiments, drug was added to cells 33 18 h before harvesting at the concentrations given. 34
For ubiquitin assay experiments, cells were co-transfected with HA-tagged ubiquitin DNA plasmid. 35
Cells were lysed 48 h after transfection in cell lysis buffer containing 10 mM N-ethylmaleimide. 36 Immunoprecipitation and Western blotting was carried out as below. 37
38
Immunoprecipitation and Western blotting 39
Transfected cells were harvested in 0.5% Triton X-100 in PBS cell lysis buffer containing enzyme 40 inhibitors. For immunoprecipitation cell lysate was pre-cleared with protein A-sepharose beads for 1-2 hours. 41
Cell lysate was then incubated with Glutathione Sepharose 4B medium (GE Healthcare, Piscataway, NJ, USA) 42
for 2 h at room temperature, primary antibody and Protein A-Sepharose 4B medium (GE Healthcare) or anti-43 FLAG Affinity Gel (Biotool, Houston, TX, USA) overnight at 4° C. Protein samples were separated by 44 electrophoresis on 4-12% NuPAGE bis-tris polyacrylamide gels (Thermo Fisher Scientific) or 4-15% Criterion 45 TGX stain-free gels (Bio-Rad Laboratories, Hercules, California, USA) and transferred to Immobilon-P PVDF 46 membranes (EMD Millipore, Billerica, MA, USA). For all experimental conditions performed in triplicate, each 47 well represents a unique transfection. Stain-free imaging was used as a total protein loading control, unless 48 otherwise stated. Membranes were blocked with 5% milk in PBS for 1 h at room temperature before incubation 49 with primary antibody in blocking buffer for 1 h at room temperature or overnight at 4° C. Appropriate HRP-50 conjugated secondary antibody in blocking buffer was added to membranes for 1 h at room temperature. 51
Membranes were developed using enhanced chemiluminescence, Western Lightning Plus-ECL (Perkin Elmer, 52
Waltham, MA, USA), and proteins were visualized using PXi digital imaging system (Syngene, Frederick, MA, 53 USA). 54
55
Statistics 56
Data are presented as individual values as well as mean ± SEM. Differences between two groups were 57 determined using two-tailed unpaired Student's t-test and differences between multiple groups were analyzed 58 using one-way ANOVA followed by Tukey's multiple comparisons test. A P value of less than 0.05 was 59 considered significant. Statistical analysis was performed using GraphPad Prism 7 software (GraphPad 60 Software, San Diego, CA, USA). 61
62

Results
63
Cul3Δ403-459 exhibits decreased interaction with JAB1 (24), suggesting that the deleted domain may include 68 the CSN binding site. The crystal structure of CSN with the highly homologous cullin 1 (12) and cullin 4A (5), 69 showed that the CSN2 subunit interacts directly with the C-terminal domain. Additionally, Min et al. (15) 70 determined that the CSN binding site for cullin 1 (which is structurally similar to Cul3) was located specifically 71 within the C-terminal domains 4HB and α/β 1 . Inspection of the Cul3 gene revealed that exon 9 (deleted in 72
FHHt-causing Cul3 mutations) encodes the 4HB domain (see Figure 1A ). To determine sites of CSN interaction 73 with Cul3, we generated Cul3 deletion constructs ( Figure 1A ). We first confirmed that, compared with WT-74
Cul3, there was minimal JAB1 precipitation by Cul3Δ403-459 ( Figure 1B) . Similarly, the Cul3 construct 75 containing N-terminal residues 1-402, which lacks the 4HB domain and the adjacent α/β 1 domain showed 76 nominal precipitation of JAB1 ( Figure 1C) . Surprisingly, inclusion of the 4HB domain with the N-terminal 77 region also showed low binding to JAB1 ( Figure 1C , Cul3 1-459). These results indicate clearly that Cul3 78 amino acids 403-459 (containing the 4HB domain) are not sufficient for binding to the CSN. This suggests that 79 the Cul3Δ403-459 mutation does not impair Cul3-CSN binding directly, but rather disrupts protein folding 80 within a site C-terminal to the 4HB domain; this suggestion is consistent with structural modeling of wild type 81 and mutant Cul3 (24). 82
To identify the specific binding site for the CSN and confirm that the 4HB does not bind JAB1 we 83 developed individual Cul3 domain constructs for 4HB and α/β 1 . Additionally, we generated a construct 84 containing both the 4HB and α/β 1 domains (4HB:α/β 1 ), an N-terminal construct containing cullin repeat 85 sequences (R1:R2:R3) and a C-terminal construct containing domains WH-A, α/β 2 , and WH-B (WH-86 A:α/β 2 :WH-B). JAB1 immunoprecipitated with the Cul3 construct containing both the 4HB and α/β 1 domains 87 and with α/β 1 alone, but not with 4HB alone ( Figure 1D ). JAB1 was not precipitated with Cul3 constructs that 88 lacked the α/β 1 domain, R1:R2:R3 and WH-A:α/β 2 :WH-B. The results indicate that the first α/β domain of Cul3 89 is the binding site for JAB1 and therefore the CSN. 90
To verify that the α/β 1 domain is the binding site for the CSN we developed a full-length Cul3 construct 91 in which the α/β 1 was deleted (Cul3Δ461-586). JAB1 was not precipitated with Cul3Δ461-586 ( Figure 1E ). As 92 expected, Cul3Δ461-586 also showed enhanced neddylation compared to WT-Cul3. These results further 93 confirm that the CSN binding site is contained within the α/β 1 domain of Cul3. 94 95 CSN inhibition enhances Cul3 neddylation and reduces KLHL3 and WNK4 abundance. 96 Neddylation of cullins has paradoxical effects, with both neddylation and deneddylation being required 97 for normal CRL function. Because Cul3Δ403-459 exhibits decreased interaction with JAB1 (24), we examined 98 the effects of inhibiting JAB1 activity on Cul3 in HEK293 cells. Cells were transfected with siRNA to reduce 99 endogenous JAB1. Western blotting for endogenous Cul3 exhibited a more neddylated Cul3 (as detected by an 00 increase in the higher molecular weight Cul3 band) when JAB1 was reduced, compared to control ( Figure 2 ). when JAB1 was knocked down, as the antibody recognized a product at the molecular weight of Cul3. The 03 effects of JAB1 inhibition on the protein abundance of the Cul3 substrate adaptor KLHL3 and substrate WNK4 04 were also determined. Abundance of overexpressed KLHL3 and WNK4 were lower, in cells transfected with 05 JAB1 siRNA, compared to control siRNA, indicating that JAB1 knockdown and increased neddylation 06 activates Cul3 in transfected cells. 07 08 Cul3Δ403-459 causes decreased stability of KLHL3 09
We showed previously that KLHL3 protein abundance was lower when co-expressed with Cul3Δ403-10 459 than with WT Cul3 in HEK293 cells (14), suggesting that degradation was more rapid in the presence of 11 mutant Cul3. To test this, we measured the stability of KLHL3 using the cycloheximide chase assay. KLHL3 12 abundance was significantly lower 24 hours after cycloheximide treatment when co-transfected with Cul3Δ403-13 459 compared to WT Cul3, but the apparent degradation rates at other time points were not different ( Figure  14 3A). As KLHL3 co-transfected with WT Cul3 was stable at least 24 h after cycloheximide treatment (the long 15 stability of KLHL3 has been previously published (17)), which can lead to anomalous results in cycloheximide 16 chase experiments (37), we decided to examine a canonical CRL substrate, WNK4, using a similar approach. 17
Similar to the Cul3-KLHL3 experiments, WNK4 was stable when cycloheximide was introduced in the absence 18 of KLHL3; however, when co-transfected together with KLHL3, WNK4 abundance was strikingly reduced 19 ( Figure 3B ). When we compared the effects of KLHL3 on WNK4 abundance with those of Cul3Δ403-459 on 20 KLHL3 abundance, the results are remarkably similar ( Figure 3C ). In fact, when other groups have examined 21 the effects of KLHL3 on WNK4 abundance, they also noted remarkably reduced WNK4 abundance in the 22 presence of KLHL3 (31). Thus, although we cannot prove that the Cul3Δ403-459 and WT Cul3 have 23 differential effects on KLHL3 synthesis, the current results, when coupled with those shown below suggest that 24 KLHL3 is degraded more rapidly by the Cul3 mutant. 25 26 Ligase-dependent and -independent effects of Cul3Δ403-459 on KLHL3 and WNK4. 27 The Cul3Δ403-459 mutation has altered ubiquitin ligase activity as shown by increased ubiquitylation of 28 KLHL3 and decreased ubiquitylation of WNK4 (14, 24 ). Yet, Cul3Δ403-459 also has ligase-independent 29 effects, such as enhanced binding to BTB-Kelch adaptors and decreased binding to CSN subunits and cullin-30 associated and NEDD8-dissociated protein 1 (CAND1) (10, 14, 24) . To try to better understand the anomalous 31 effects of the Cul3Δ403-459 protein we generated a neddylation-deficient Cul3Δ403-459 double mutant, 32
Cul3Δ403-459 K712R. Neddylation is generally considered to be necessary to activate CRLs. The RING 33 subunit utilizes specific E1 and E2 enzymes to covalently attach a NEDD8 protein to lysine 712 of Cul3 (33). neddylation occurs at the lysine 712 residue. Co-immunoprecipitation of the different Cul3 constructs and 38 KLHL3 showed that similar to Cul3Δ403-459, Cul3Δ403-459 K712R bound to more KLHL3 protein compared 39 to WT-Cul3 ( Figure 4B ), confirming that neddylation, and therefore ubiquitin ligase activity, is not required for 40 increased protein binding. 41
Ubiquitylation of the BTB-adaptor KLHL3 ( Figure 4C ) was greater in cells transfected with Cul3Δ403-42 459, compared to WT-Cul3, as reported previously (14). As expected, this greater KLHL3 ubiquitylation was 43 not apparent when the neddylation deficient Cul3Δ403-459 K712R was transfected. Yet the current results also 44 suggest that ubiquitin ligase activity is not fully responsible for the anomalous Cul3Δ403-459 activity. In cells 45 transfected with both KLHL3 and WNK4, the abundance of KLHL3 was lower, when Cul3Δ403-459 was 46 present than with WT-Cul3, consistent with increased substrate adaptor ubiquitylation and degradation by the 47 mutant protein ( Figure 4D ). Cul3Δ403-459 also led to more WNK4 abundance than did WT-Cul3 ( Figure 4D ), 48 as we, and others, have reported previously. When the ligase-deficient Cul3Δ403-459 K712R construct was 49 transfected, however, the effects on KLHL3 and WNK4 were reduced compared to Cul3Δ403-459 toward 50 normal (WT-Cul3) levels, ( Figure 4D ). Unexpectedly, the effects of Cul3Δ403-459 on KLHL3 were not 51 completely removed by the ligase-deficient Cul3Δ403-459 K712R double mutant, indicating that the effects of 52
Cul3Δ403-459 is only partially dependent on ubiquitin ligase activity. 53 54 Cul3Δ403-459-mediated KLHL3 degradation is both proteasome-and autophagy-dependent. 55
As shown above, when ubiquitin ligase activity is lacking, as in the Cul3Δ403-459 K712R double 56 mutant, there is less abundance of KLHL3, however, the amount of KLHL3 abundance retained by the 57 construct (ligase-independent degradation) is still significant. Since the neddylation-deficient construct should 58 block the ubiquitin-proteasome degradation pathway, the remaining Cul3Δ403-459-mediated KLHL3 59 degradation could be autophagy-dependent. The proteasome is the canonical pathway for degrading 60 ubiquitylated proteins, and it has been shown to contribute to WNK kinase degradation (14); yet there is also 61 evidence that KLHL3 and WNK4 can be degraded via autophagy (16). To determine the pathways involved in 62
Cul3Δ403-459-mediated KLHL3 degradation, we used the inhibitors MG132 and chloroquine. Proteasomal 63 inhibition with 10 M MG132 had no effect on the control group, but partially suppressed Cul3Δ403-459-64 mediated KLHL3 degradation ( Figure 5 ). Inhibition of autophagy with 100 µM chloroquine, however, had a 65 small but significant effect on the control group, indicating that KLHL3 is constitutively degraded via 66 autophagy ( Figure 6A ). Incubation of Cul3Δ403-459 with chloroquine also resulted in a partial suppression of 67 KLHL3 degradation. The percent change in KLHL3 protein abundance due to chloroquine administration was 68 significantly different between control and Cul3Δ403-459 ( Figure 6B ), which indicates an increased autophagic 69 degradation of KLHL3 mediated by the Cul3 mutant. To confirm these results, we treated cells with another 70 autophagy blocker, 3-methylandenine (3-MA), an inhibitor of autophagosome formation ( Figure 6C ). The 71 results closely resembled chloroquine administration further indicating autophagic KLHL3 degradation.
Treatment of the cells with both MG132 and chloroquine completely abolished Cul3Δ403-459-mediated 73 KLHL3 degradation ( Figure 6D ). The data suggest that, under the conditions provided, KLHL3 is degraded by 74
Cul3Δ403-459 through both the ubiquitin-proteasome pathway and the autophagy pathway. Thus, WT-Cul3 and 75
Cul3Δ403-459 degrade WNK4 and KLHL3, respectively, via two different pathways. WNK4 is ubiquitylated 76 and degraded through the proteasomal pathway. KLHL3 is degraded by both the proteasome and the autophagy 77 pathway. 78 79 Increasing KLHL3 expression normalizes Cul3Δ403-459-mediated inhibition of WNK4 degradation in the 80 presence of We suggested previously that the increased activity of Cul3Δ403-459 toward KLHL3 reduced the 82 availability of KLHL3 to participate in degrading WNK kinases (14). Alternatively, others have suggested that 83 the increased association of Cul3Δ403-459 with KLHL3 may sequester it, and accomplish the same effect. If 84 the low level of KLHL3 contributes to the increase in WNK4 in Cul3Δ403-459 patients, then increasing the 85 amount of KLHL3 should reduce WNK4. By increasing the amount KLHL3 DNA transfected into the cells we 86 were able to increase KLHL3 protein abundance. In HEK293 cells that lack Cul3 (HEK293T Cul3-KO ), an 87 increase in KLHL3 protein levels caused only a slight reduction in WNK4 abundance (28%); WNK4 was still 88 substantially higher than in cells transfected with WT-Cul3, even though KLHL3 protein abundance was similar 89 (compare the first and last three lanes in Figure 7A) . However, in HEK293 cells that contained endogenous 90 WT-Cul3 ( Figure 7B ), increasing KLHL3 protein levels in cells transfected with Cul3Δ403-459 caused a 91 striking reduction in WNK4 protein abundance (64%), to a value that was not significantly different from WT-92
Cul3 transfected cells. The data show that Cul3Δ403-459 itself is unable to substantially degrade WNK4, even 93 when KLHL3 is normalized, but when Cul3Δ403-459 and Cul3 are both present in cells, as they are in 94 heterozygous humans, the addition of KLHL3 normalizes degradation of WNK4. This suggests that, in vitro, 95
Cul3Δ403-459 degrades KLHL3, preventing WT-Cul3 from binding to WNK4. 96 97
Cul3Δ403-459 exhibits a dominant effect in cells. 98
It has been suggested that Cul3Δ403-459 causes FHHt by inducing functional Cul3 haploinsufficiency, 99 (10, 24). This suggestion derives from the observation that the abundance of Cul3Δ403-459 is very low in a 00
knock-in mouse model of FHHt, and also that introducing a 1:1 molar ratio of WT-Cul3 to Cul3Δ403-459 did 01 not inhibit ubiquitylation of WNK4 (24). Yet Uchida and colleagues noted that mice with functional Cul3 02 haploinsufficiency do not exhibit signs of FHHt (2), and as noted above, Cul3Δ403-459 may either degrade 03 and/or sequester KLHL3, thereby exerting a dominant negative effect (10, 14) . To determine whether 04
Cul3Δ403-459 has dominant effects in cells, we transfected both WT-Cul3 and Cul3Δ403-459 together at 05 different ratios. In the presence of constant WT-Cul3, increasing Cul3Δ403-459 reduced KLHL3 abundance increased KLHL3 and decreased WNK4. Thus, Cul3Δ403-459 clearly exerts a dominant effect in cultured cells; 08 this is consistent with the autosomal dominant inheritance of FHHt type 4. 09 10
Cul3Δ403-459 does not affect Keap1 and cyclin E protein abundance 11
Because Cul3 can interact with and ubiquitinate multiple substrates through many different substrate 12 adaptors, then it would be expected that the Cul3Δ403-459 mutant would affect other proteins besides KLHL3 13 and WNK4. To better understand the effects of the Cul3Δ403-459 mutant, we examined three other proteins 14 that interact with Cul3. The oxidative stress response protein, nuclear factor erythroid 2-related factor 2 (Nrf2), 15 is another substrate of Cul3 and interacts through the BTB-Kelch substrate adaptor protein kelch-like ECH-16 associated protein-1 (Keap1). Unlike KLHL3, Keap1 showed no change in protein abundance when cells were 17 transfected with Cul3Δ403-459 or Cul3Δ403-459 K712R (Figure 9 ). Although Keap1 was unchanged, its 18 substrate Nrf2 showed an increase in protein abundance in Cul3Δ403-459 transfected cells. The amplified Nrf2 19 was also observed in cells transfected with Cul3Δ403-459 K712R. Cyclin E, which is a canonical Cul3 20 substrate and is involved in cell cycle regulation, was unchanged when transfected with Cul3Δ403-459 or 21
Cul3Δ403-459 K712R. The results demonstrate that the Cul3Δ403-459 mutant has differential effects on its 22
substrates and substrate adaptors. Mutations in WNK1, WNK4, Cul3, and KLHL3 cause FHHt, predominantly by increasing NCC activity 26 along the DCT, suggesting that these proteins comprise a single signaling pathway. The disease pathogenesis, in 27
all cases, appears to result from an increase in WNK kinase abundance, either owing to enhanced transcription, 28 or impaired degradation. While WNK4 and KLHL3 mutations impair the degradative arm of this pathway by 29 disrupting the ability of WNK kinases to form complexes with KLHL3 and Cul3, the mechanisms involved in 30
Cul3 disease have been more difficult to unravel (17, 18, 25, 28, 29, 31, 34) . We reported previously that the 31
FHHt-mutant Cul3 ubiquitylates and facilitates KLHL3 degradation more actively than does WT-Cul3, and 32 suggested that the mutant exhibits dominant effects (14). The dominant nature of the Cul3Δ403-459 mutation 33 was very recently confirmed, using mouse models (9). Here we determined that Cul3Δ403-459 has an altered 34 structure that decreases interaction with the CSN. Yet the results also discern a novel, secondary, ligase-35 independent autophagocytic KLHL3 degradation pathway that appears essential for the autosomal dominant 36 phenotype. 37
The current results confirm our prior work (14), indicating that that Cul3Δ403-459 is hyperneddylated, 38 when expressed in cells. Ibeawuchi and colleagues (10), in contrast, could not detect hyperneddylation of 39
Cul3Δ403-459 and suggested that the mutant protein is neddylated less efficiently than WT. A potential 40 resolution to this paradox is apparent from the work of Schumacher and colleagues (24), who also documented They demonstrated that the defect lies in a failure of the CSN to associate with Cul3, and therefore, a failure of 43 deneddylation. The current work confirms that Cul3Δ403-459 does not associate normally with the CSN (in this 44 case, the catalytically-active JAB1 subunit), but this effect is not because the deleted amino acid sequence 45 actually binds to JAB1. FHHt-causing Cul3 mutations lead to deletion of exon 9, which encodes the 4HB 46 domain ( Figure 1A) . Min et al. (15) examined the CSN binding domain of a homologous cullin, cullin 1, and 47 suggested that it lies within the 4HB domain. To determine whether the same domain is relevant in Cul3 48 binding to CSN, we mapped the Cul3 domains that are required for association with JAB1. Using multiple Cul3 49 constructs, we determined that the 4HB domain is neither necessary nor sufficient for CSN binding. Instead, the 50 α/β 1 domain, which lies adjacent to the 4HB domain, was identified as essential for association with the CSN. 51
Since the α/β 1 domain is not directly altered by the Cul3Δ403-459 mutation, the results suggest that the 52 mutation disrupts binding to the CSN through alterations in the protein folding of Cul3; this suggestion aligns 53 with the structural modeling data of Schumacher and colleagues (24). 54
Since Cul3Δ403-459 does not bind efficiently to JAB1 protein we tested whether JAB1 knockdown 55 could mimic the effects of Cul3Δ403-459 in cultured cells. Knockdown of JAB1 with siRNA decreased, rather 56 than increased, WNK4 protein abundance indicating increased CRL activity (Figure 2 ). This suggests that JAB1 57 knockdown alone cannot mimic Cul3Δ403-459 effects on WNK4; it should be noted, however, that CRL 58 activity can differ between cell culture models and in vivo. The CSN positively regulates CRLs in vivo (22), 59
whereas in vitro CRLs are negatively regulated by the CSN (36). Further, in vivo, experiments are needed to 60 fully understand the effects of JAB1 inhibition. 61
The Cul3Δ403-459 K712R mutant prevented NEDD8 conjugation, effectively inhibiting ubiquitin ligase 62 activity. However, Cul3Δ403-459 K712R, unexpectedly, still showed significant degradation of KLHL3 ( Figure  63 4D), suggesting that degradation might be due to a non-ligase effect of the mutant Cul3Δ403-459. The results 64 suggest that this ligase-independent degradation of KLHL3 occurs through the autophagy pathway, as two 65 different inhibitors of this pathway, chloroquine, and 3-MA, both prevented KLHL3 degradation. Thus, as the 66 schematic depicts in Figure 10 , Cul3Δ403-459 facilitates KLHL3 degradation through two different pathways. 67 KLHL3 is ubiquitylated and degraded via the proteasome. Additionally, KLHL3 can be degraded via selective 68 autophagy, which is stimulated by the Cul3 mutant in a ligase-independent manner. Furthermore, the results 69 here suggest that degradation of KLHL3 contributes importantly to WNK4 accumulation in FHHt. As shown, in 70 the absence of WT-Cul3 (in HEK293T Cul3-KO cells), Cul3Δ403-459 cannot degrade WNK4, even when KLHL3 71 is abundant ( Figure 7A ). In cells that simultaneously express WT-Cul3 with Cul3Δ403-459, however, KLHL3 72 abundance proves limiting for WNK4 degradation ( Figure 7B ), and thus it is the ability of the mutant Cul3 to 73 drive KLHL3 degradation that proves essential. These observations provide substantial insight into the 74 mechanisms of the disease, which is characterized by the presence of one WT and one mutant Cul3 allele. In is limited by the low abundance of KLHL3; this is maintained by enhanced proteasomal-and autophagy-driven 78 KLHL3 degradation (Figure 10) . 79
The Cul3 mutation is contained within a protein that is a part the UPS, yet Cul3Δ403-459 causes an 80 increase in autophagic degradation of KLHL3 ( Figure 6B ). The reason for this could be due to the relationship 81 between the two degradative pathways. The UPS and autophagy were once thought to be separate mechanisms 82 for regulated protein turnover, however, recent work has demonstrated that the two pathways may not be 83 independent of one another. First, inhibition of the proteasome causes an increase in autophagy (8). This is most 84 likely due to the fact that many proteins involved in the autophagy pathway are substrates for E3 ubiquitin 85 ligases, including CRLs, and are negatively regulated via the UPS (7). Additionally, ubiquitylated proteins can 86 be shuttled to the autophagophore (the vesicle that ultimately binds to the lysosome) via a linker protein, such as 87 p62 (11). These proteins connect the two pathways by binding to both ubiquitylated proteins and 88 autophagophore-membrane proteins allowing for ubiquitylated proteins to be degraded via autophagy. p62 89 binds to KLHL3 and mediates its degradation via autophagy when the proteasomal pathway is inhibited (16). 90
Thus, the Cul3 mutation could lead to upregulation of p62-mediated autophagic degradation of KLHL3; 91 moreover, the impairment of CRL substrate degradation, as shown with the Cul3 mutant, could cause activation 92 of autophagy due to accumulation of CRL substrates that are critical for the process. 93
CRLs can associate with hundreds of substrate adaptors which can target thousands of substrates. Global 94 deletion of the Cul3 gene is embryonic lethal in mice (26). So, the fact that Cul3Δ403-459 doesn't produce 95
widespread phenotypic effects has been perplexing. Here, we suggest that this paradox is resolved by dual 96 effects of the Cul3Δ403-459 mutant protein, loss of function with respect to WNK4 degradation, and gain of 97 function with respect to autophagocytic degradation of KLHL3. The latter effect likely contributes to the 98 apparent tissue specificity for the disease to disrupt kidney and vascular smooth muscle. Although Cul3Δ403-99 459 avidly binds to and degrades KLHL3, its effects on other adaptor proteins are different. The substrate 00 adaptors Bacurd1 and RhoBTB1 similarly showed higher levels of interaction with Cul3Δ403-459 compared to 01 WT-Cul3 (10). Yet, Cul3Δ403-459 degraded RhoBTB1 less efficiently compared to WT-Cul3, and Bacurd1 02 showed no change in abundance. Here, Keap1, also known as Kelch-like 19, like Bacurd1, did not show a 03 change in protein abundance due to Cul3Δ403-459 ( Figure 9 ). Although Cul3Δ403-459 has differential effects 04 on these substrate adaptors, the effects of Cul3Δ403-459 on their respective substrates were similar. Analogous 05 to WNK4, the Bacurd1 substrate RhoA, which is expressed in the vascular smooth muscle and important for 06 arterial pressure regulation, was upregulated by Cul3Δ403-459 (1). Additionally, as shown above, the Keap1 07 substrate and oxidative stress response protein, Nrf2, showed increased protein abundance (Figure 9 ). On the 08 other hand, cyclin E, a protein involved in cell cycle regulation and a substrate of Cul3, was unaffected by a few adaptors that undergoes active degradation, providing specificity for tissues and cell types in which this 12 protein is highly expressed. 13
All FHHt patients reported to date who harbor mutations in Cul3 are heterozygous (4). Some have 14 suggested that the Cul3Δ403-459 protein is unstable, leading to functional haploinsufficiency of the wild type 15 protein; according to this model, individuals with one functional Cul3 allele should exhibit the phenotype (1, 16 24 ). Yet, Uchida and colleagues generated a mouse model that lacked one Cul3 allele, expressing approximately 17 half as much Cul3 protein as control mice; the mice, however, did not show any evidence of the FHHt 18 phenotype (2). Further, Ferdaus and colleagues (9) recently showed that mice with one Cul3 allele also lack 19 features of FHHt, whereas mice with one mutant and one wild type allele exhibit frank hyperkalemic 20 hypertension. While the protein derived from Cul3Δ403-459 does appear to be unstable, in vivo (1, 24), the 21 current results suggest that the FHHt phenotype requires a second, dominant-negative effect. In support of this, 22
we found clear evidence for a dominant effect of Cul3Δ403-459 on Cul3 WT, when the ratio of WT to mutant 23 construct was varied (Figure 8 ). This is largely consistent with the model suggested by Sigmund and colleagues, 24 who found that Cul3Δ403-459 exhibited enhanced interaction with substrate adaptors, such as KLHL3, and 25 suggested that the mutant cullin might act in a dominant manner, despite reduced abundance, by sequestering 26 adaptor proteins (10). 27
The results here show only a modest change in WNK4 when WT Cul3 and Cul3Δ403-459 are 28 transfected together, and increasing the ratio of WT Cul3 to Cul3Δ403-459 further diminished the effects on 29 WNK4 abundance. This raises questions about the direct relevance of this to the human disease, as all FHHt 30 patients are heterozygous, with one WT and one mutant allele. Additionally, in experimental disease models, 31 the abundance of Cul3Δ403-459 is very low, relative to the wild type allele. Yet, Ferdaus and colleagues (9) 32 showed recently that Cul3Δ403-459 exerts dominant effects, in vivo, despite its low abundance. Thus, these 33 limitations of using HEK293 cells imply that these hypotheses should be explored using physiologically more 34 relevant model systems. 35
Thus, the current results clarify the consequences of deletion of exon 9 in Cul3, and provide novel 36 information about how Cul3 interacts with the CSN. They suggest that this interaction requires the α/β 1 domain, 37 which lies next to, but is distinct from, the 4HB domain deleted in the human disease. Thus, although the 38 deletion impairs binding of Cul3 to the CSN, the deleted region itself does not mediate the association. 39
Furthermore, the results stress the importance of KLHL3 in the regulation of WNK4. Our data would be 40 consistent with an effect of the mutant Cul3 protein to bind avidly to specific substrate adaptors, forming 41 unstable and ineffective complexes. Additional studies will be required to further evaluate this hypothesis. constructs with (1-459) and without (1-402) the 4HB domain showed no binding to JAB1. D) Segments 91 of the Cul3 protein were generated with a GST tag and co-transfected with myc-tagged JAB1. Co-92 immunoprecipitation was performed using glutathione sepharose beads. Immunoblotting for JAB1 93 showed binding to 4HB:α/β 1 and α/β 1 Cul3 constructs, but not to 4HB, WH-A:α/β:WH-B, or R1:R2:R3 94 Cul3 constructs. E) Co-immunoprecipitation was performed with myc-JAB1 and FLAG-tagged WT-95
Cul3 or Cul3Δ461-586 constructs. Cul3Δ461-586 demonstrated less binding to JAB1 protein compared 96 to WT-Cul3. Immunoblotting for NEDD8 showed enhanced neddylation of the Cul3Δ461-586 construct 97 compared to WT-Cul3. The asterisk indicates a nonspecific band. 98 The proteins were examined by immunoblot in cells with endogenous WT-Cul3. JAB1 siRNA decreased 01 JAB1, KLHL3, and WNK4 abundance, increased NEDD8 abundance, and the neddylated form of Cul3 02 (top band). β-actin was used as a loading control. 03 with HEK293 cells co-transfected with myc-tagged KLHL3 and either FLAG-WT Cul3 or FLAG-05
Cul3Δ403-459. Due to a robust decrease in KLHL3 by the Cul3Δ403-459 which prevented 06 quantification, the amount of Cul3Δ403-459 transfected was reduced to half of WT Cul3. 07
Cycloheximide (100 µg/ml) was added 36 h post transfection and cells were lysed at 0, 1, 2, 4, 8, and 24 08 h time points. KLHL3 protein abundance was more rapidly degraded in cells co-expressing Cul3Δ403-09 459. Right, quantitative analysis of KLHL3 protein abundance. Stain-free imaging was used as a loading 10 control. Linear regression was used to determine the slope of each group. The differences between the 11 slopes were significantly different (P < 0.001). Data represent mean values ± SEM relative to the 0 h 12 time point. Statistical differences were examined using two-tailed unpaired Student's t test. * P = 0.01 13 vs WT. B. Cycloheximide chase assay was performed with HEK293 cells co-transfected with myc-14 tagged WNK4 in the presence or absence of KLHL3. Cycloheximide (100 µg/ml) was added 36 h post 15 transfection and cells were lysed at 0, 2, 4, and 6 h time points. Stain-free imaging was used as a loading Right, quantitative analysis of WNK4 protein abundance; all data points are relative to WNK4 without 18 KLHL3 0 h time point. The effects of Cul3Δ403-459 on KLHL3 abundance is similar to the effects of 19 KLHL3 on WNK4 abundance. 20 immunoprecipitated using FLAG antibody. Immunoblotting for NEDD8 showed no neddylation of the 23 K712R mutant for both WT-Cul3 and Cul3Δ403-459. B) Co-immunoprecipitation was performed with 24 HEK293 cells transfected with myc-KLHL3 and FLAG-tagged WT-Cul3, Cul3Δ403-459, Cul3Δ403-25 459 K712R, or empty vector. Pull-down with FLAG antibodies showed that KLHL3 had more binding 26
to Cul3Δ403-459 and Cul3Δ403-459 K712R proteins. C) A ubiquitin assay was performed for KLHL3 27 by co-transfecting FLAG-tagged Cul3 constructs with myc-KLHL3 and HA-tagged ubiquitin. WT-Cul3 to Cul3Δ403-459 was adjusted as labeled and analyzed by immunoblot. β-actin was used as a 72 loading control. Increasing the ratio of Cul3Δ403-459 to WT-Cul3 decreased KLHL3 and increased 73 WNK4 protein expression. The opposite was observed when increasing the ratio of WT-Cul3 to 74
Cul3Δ403-459. Bar graphs are a summary of the densitometry analysis of the blot. 75 
